OpenAlex
PricingAboutJobs
Log inGet started
Work

A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide

HTML

Year: 2012
Type: article
Source: Blood
DOI: 10.1182/blood-2011-08-373514
Authors: Meletios A. Dimopoulos, Paul G. Richardson, Nancy Brandenburg, Zhinuan Yu, Donna M. Weber, Ruben Niesvizky, Gareth J. Morgan
Institutions: National and Kapodistrian University of Athens, Dana-Farber Cancer Institute, Celgene (United States), The University of Texas MD Anderson Cancer Center, Cornell University, Weill Cornell Medicine, Institute of Cancer Research, Royal Marsden Hospital
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: second primary malignancy, lenalidomide, relapsed/refractory multiple myeloma, lenalidomide-dexamethasone, non-melanoma skin cancer, cancer risk, drug safety, risk-benefit assessment
SDG: Good health and well-being

Open Access status: closed

Funder: Celgene
OpenAlex ID: W2080030013
FWCI: 15.21
Cites: 22
Cited by: 153
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security